Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Vockenhuber

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Leukemia & Lymphoma|May 13, 2022
Efficacy and safety of voriconazole as invasive fungal infection prophylaxis in patients with acute myeloid leukemiaSigrid Machherndl-Spandl, Thomas Vockenhuber, Michaela Binder, et al.
JACC. Case Reports|September 30, 2025
Successful Use of Ruxolitinib for Steroid-Refractory Immune Checkpoint Inhibitor-Associated MyocarditisThomas Vockenhuber, Lukas Baldinger, Johannes Clausen, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Leukemia & Lymphoma|May 13, 2022
Efficacy and safety of voriconazole as invasive fungal infection prophylaxis in patients with acute myeloid leukemiaSigrid Machherndl-Spandl, Thomas Vockenhuber, Michaela Binder, et al.
JACC. Case Reports|September 30, 2025
Successful Use of Ruxolitinib for Steroid-Refractory Immune Checkpoint Inhibitor-Associated MyocarditisThomas Vockenhuber, Lukas Baldinger, Johannes Clausen, et al.
Pageof 1